Advertisement

Postoperative heart failure after stage 1 palliative surgery for single ventricle cardiac disease

  • Michael G. Foulks
  • Rika M. L. Meyer
  • Jeffrey I. Gold
  • Cynthia S. Herrington
  • Kristopher Kallin
  • JonDavid MenteerEmail author
Original Article

Abstract

Outcomes for patients with single ventricle congenital heart disease (SV-CHD) continue to improve over time. However, the prognosis for patients who develop heart failure immediately after surgery is poorly understood. We conducted a single-center, retrospective cohort study of patients with SV-CHD, who suffered postoperative heart failure. Of 1038 cardiac surgeries performed on 621 SV-CHD patients between 2004 and 2010, 125 patients met inclusion criteria, including non-septatable anatomy, stage 1 surgery, and verified low cardiac output or heart failure state per STS definition. Overall survival was 73.2% at 2 months, 64.9% at 1 year, 60.5% at 2 years, and 54.6% at 4 years. Inotrope dependence beyond 7 days post-op yielded 45% 2-year survival versus 68% for those who weaned from inotropes within 7 days (p = 0.02). Atrioventricular valve regurgitation (AVVR) influenced survival, and patients who developed renal failure or required ECMO fared poorly, even when they survived their hospitalization. Patients with postoperative heart failure and low cardiac output syndrome constitute a high-risk population beyond the term of the initial hospitalization and have an overall mid-term survival of 55% at 4 years. Wean from inotropic therapy is not completely reassuring in this population, as they have ongoing elevated risk of cardiac failure and death in the medium term. Ventricular dysfunction, AVVR, renal failure, and need for ECMO are all important prognostic factors for mid-term mortality. Inotrope dependence for > 7 days has important implications reaching beyond the hospitalization.

Keywords

Congenital heart disease Postoperative outcomes Heart failure Pediatric critical care Hypoplastic left heart syndrome Infants 

Notes

Compliance with ethical standards

Conflict of interest

Michael G Foulks declares that he has no conflict of interest to disclose. Rika M. L. Meyer declares that she has no conflict of interest to disclose. Jeffrey I. Gold declares that he has no conflict of interest to disclose. Cynthia S. Herrington declares that she has no conflict of interest to disclose. Kristopher Kallin declares that he has no conflict of interest to disclose. JonDavid Menteer declares that he has no conflict of interest to disclose.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was not obtained from all individual participants included in the study.

References

  1. 1.
    Azakie T, Merklinger SL, McCrindle BW, Van Arsdell GS, Lee KJ, Benson LN, Coles JG, Williams WG (2001) Evolving strategies and improving outcomes of the modified norwood procedure: a 10-year single-institution experience. Ann Thorac Surg 72:1349–1353CrossRefGoogle Scholar
  2. 2.
    Bove EL, Lloyd TR (1996) Staged reconstruction for hypoplastic left heart syndrome. Contemporary results. Ann Surg 224:387–394 (discussion 394–385) CrossRefGoogle Scholar
  3. 3.
    Ohye RG, Sleeper LA, Mahony L, Newburger JW, Pearson GD, Lu M, Goldberg CS, Tabbutt S, Frommelt PC, Ghanayem NS, Laussen PC, Rhodes JF, Lewis AB, Mital S, Ravishankar C, Williams IA, Dunbar-Masterson C, Atz AM, Colan S, Minich LL, Pizarro C, Kanter KR, Jaggers J, Jacobs JP, Krawczeski CD, Pike N, McCrindle BW, Virzi L, Gaynor JW, Investigators PHN (2010) Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med 362:1980–1992CrossRefGoogle Scholar
  4. 4.
    Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ (2010) Changing mortality in congenital heart disease. J Am Coll Cardiol 56:1149–1157CrossRefGoogle Scholar
  5. 5.
    Ghanayem NS, Hoffman GM, Mussatto KA, Cava JR, Frommelt PC, Rudd NA, Steltzer MM, Bevandic SM, Frisbee SS, Jaquiss RD, Litwin SB, Tweddell JS (2003) Home surveillance program prevents interstage mortality after the Norwood procedure. J Thorac Cardiovasc Surg 126:1367–1377CrossRefGoogle Scholar
  6. 6.
    Petit CJ, Fraser CD, Mattamal R, Slesnick TC, Cephus CE, Ocampo EC (2011) The impact of a dedicated single-ventricle home-monitoring program on interstage somatic growth, interstage attrition, and 1-year survival. J Thorac Cardiovasc Surg 142:1358–1366CrossRefGoogle Scholar
  7. 7.
    Dobrolet NC, Nieves JA, Welch EM, Khan D, Rossi AF, Burke RP, Zahn EM (2011) New approach to interstage care for palliated high-risk patients with congenital heart disease. J Thorac Cardiovasc Surg 142:855–860CrossRefGoogle Scholar
  8. 8.
    Feinstein JA, Benson DW, Dubin AM, Cohen MS, Maxey DM, Mahle WT, Pahl E, Villafañe J, Bhatt AB, Peng LF, Johnson BA, Marsden AL, Daniels CJ, Rudd NA, Caldarone CA, Mussatto KA, Morales DL, Ivy DD, Gaynor JW, Tweddell JS, Deal BJ, Furck AK, Rosenthal GL, Ohye RG, Ghanayem NS, Cheatham JP, Tworetzky W, Martin GR (2012) Hypoplastic left heart syndrome: current considerations and expectations. J Am Coll Cardiol 59:S1–S42CrossRefGoogle Scholar
  9. 9.
    McKenzie ED, Khan MS, Samayoa AX, Vener DS, Ishak YM, Santos AB, Heinle JS, Fraser CD (2013) The Blalock-Taussig shunt revisited: a contemporary experience. J Am Coll Surg 216:699–704 (discussion 704–696) CrossRefGoogle Scholar
  10. 10.
    Petrucci O, O’Brien SM, Jacobs ML, Jacobs JP, Manning PB, Eghtesady P (2011) Risk factors for mortality and morbidity after the neonatal Blalock-Taussig shunt procedure. Ann Thorac Surg 92:642–651 (discussion 651–642) CrossRefGoogle Scholar
  11. 11.
    Honjo O, Mertens L, Van Arsdell GS (2011) Atrioventricular valve repair in patients with single-ventricle physiology: mechanisms, techniques of repair, and clinical outcomes. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 14:75–84CrossRefGoogle Scholar
  12. 12.
    Hirsch JC, Ohye RG, Devaney EJ, Goldberg CS, Bove EL (2007) The lateral tunnel Fontan procedure for hypoplastic left heart syndrome: results of 100 consecutive patients. Pediatr Cardiol 28:426–432CrossRefGoogle Scholar
  13. 13.
    Mitchell ME, Ittenbach RF, Gaynor JW, Wernovsky G, Nicolson S, Spray TL (2006) Intermediate outcomes after the Fontan procedure in the current era. J Thorac Cardiovasc Surg 131:172–180CrossRefGoogle Scholar
  14. 14.
    Khairy P, Fernandes SM, Mayer JE, Triedman JK, Walsh EP, Lock JE, Landzberg MJ (2008) Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 117:85–92CrossRefGoogle Scholar
  15. 15.
    d’Udekem Y, Iyengar AJ, Cochrane AD, Grigg LE, Ramsay JM, Wheaton GR, Penny DJ, Brizard CP (2007) The Fontan procedure: contemporary techniques have improved long-term outcomes. Circulation 116:I157–I164Google Scholar
  16. 16.
    Salazar JD, Zafar F, Siddiqui K, Coleman RD, Morales DL, Heinle JS, Rossano JW, Mossad EB, Fraser CD (2010) Fenestration during Fontan palliation: now the exception instead of the rule. J Thorac Cardiovasc Surg 140:129–136CrossRefGoogle Scholar
  17. 17.
    Starnes VA, Griffin ML, Pitlick PT, Bernstein D, Baum D, Ivens K, Shumway NE (1992) Current approach to hypoplastic left heart syndrome. Palliation, transplantation, or both? J Thorac Cardiovasc Surg 104:189–194 (discussion 194–185) Google Scholar
  18. 18.
    Vouhé PR, Tamisier D, Le Bidois J, Sidi D, Mauriat P, Pouard P, Lefebvre D, Albanese SB, Khoury W, Kachaner J (1993) Pediatric cardiac transplantation for congenital heart defects: surgical considerations and results. Ann Thorac Surg 56:1239–1247CrossRefGoogle Scholar
  19. 19.
    Backer CL, Zales VR, Idriss FS, Lynch P, Crawford S, Benson DW, Mavroudis C (1992) Heart transplantation in neonates and in children. J Heart Lung Transplant 11:311–319Google Scholar
  20. 20.
    Bacha EA (2013) Individualized approach in the management of patients with hypoplastic left heart syndrome (HLHS). Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 16:3–6CrossRefGoogle Scholar
  21. 21.
    Griffiths ER, Kaza AK, Wyler von Ballmoos MC, Loyola H, Valente AM, Blume ED, del Nido P (2009) Evaluating failing Fontans for heart transplantation: predictors of death. Ann Thorac Surg 88:558–563 (discussion 563–554) CrossRefGoogle Scholar
  22. 22.
    Jean-St-Michel E, Chetan D, Schwartz SM, Van Arsdell GS, Floh AA, Honjo JC (2016) Outcomes in patients with persistent ventricular dysfunction after stage I palliation for hypoplastic left heart syndrome. Pediatr Cardiol 37:239–243CrossRefGoogle Scholar
  23. 23.
    Honjo O, Atlin CR, Mertens L, Al-Radi OO, Redington AN, Caldarone CA, Van Arsdell GS (2011) Atrioventricular valve repair in patients with functional single-ventricle physiology: impact of ventricular and valve function and morphology on survival and reintervention. J Thorac Cardiovasc Surg 142:326–335.e322CrossRefGoogle Scholar
  24. 24.
    Mahle WT, Gaynor JW, Spray TL (2001) Atrioventricular valve replacement in patients with a single ventricle. Ann Thorac Surg 72:182–186CrossRefGoogle Scholar
  25. 25.
    Imai Y, Takanashi Y, Hoshino S, Terada M, Aoki M, Ohta J (1997) Modified Fontan procedure in ninety-nine cases of atrioventricular valve regurgitation. J Thorac Cardiovasc Surg 113:262–268 (discussion 269) CrossRefGoogle Scholar
  26. 26.
    Mahle MT, Hu C, Trachtenberg F, Menteer JD, Kindel SJ, Dipchand AI, Richmond ME, Daly KP, Henderson HT, Lin K, McCulloch M, Lal AK, Schimacher KR, Jacobs JP, Atz AM, Villa CR, Burns KM, Newburger JW (2018) Heart failure following the Norwood procedure: an analysis of the single ventricle reconstruction trial. J Heart Lung Transplant 37:879–885CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of AnesthesiaUniversity of Washington Medical CenterSeattleUSA
  2. 2.Department of Child and Adolescent DevelopmentCalifornia State UniversityNorthridgeUSA
  3. 3.Keck School of Medicine, Department of PediatricsUniversity of Southern CaliforniaLos AngelesUSA
  4. 4.Division of Cardiothoracic SurgeryChildren’s Hospital Los AngelesLos AngelesUSA
  5. 5.Cardiovascular SurgeryKaiser Permanente Los AngelesLos AngelesUSA
  6. 6.Division of CardiologyChildren’s Hospital Los AngelesLos AngelesUSA

Personalised recommendations